JP2012520269A5 - - Google Patents

Download PDF

Info

Publication number
JP2012520269A5
JP2012520269A5 JP2011553476A JP2011553476A JP2012520269A5 JP 2012520269 A5 JP2012520269 A5 JP 2012520269A5 JP 2011553476 A JP2011553476 A JP 2011553476A JP 2011553476 A JP2011553476 A JP 2011553476A JP 2012520269 A5 JP2012520269 A5 JP 2012520269A5
Authority
JP
Japan
Prior art keywords
amino
piperazin
thiazolo
fluorophenyl
pyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011553476A
Other languages
English (en)
Japanese (ja)
Other versions
JP5647998B2 (ja
JP2012520269A (ja
Filing date
Publication date
Priority claimed from GB0904353A external-priority patent/GB0904353D0/en
Priority claimed from GB0904373A external-priority patent/GB0904373D0/en
Priority claimed from GB0911022A external-priority patent/GB0911022D0/en
Application filed filed Critical
Priority claimed from PCT/EP2010/053318 external-priority patent/WO2010103130A2/en
Publication of JP2012520269A publication Critical patent/JP2012520269A/ja
Publication of JP2012520269A5 publication Critical patent/JP2012520269A5/ja
Application granted granted Critical
Publication of JP5647998B2 publication Critical patent/JP5647998B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011553476A 2009-03-13 2010-03-15 免疫抑制剤としてのチアゾロピリミジン調節因子 Expired - Fee Related JP5647998B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0904353A GB0904353D0 (en) 2009-03-13 2009-03-13 Novel thiazolopyrimidines
GB0904373.8 2009-03-13
GB0904353.0 2009-03-13
GB0904373A GB0904373D0 (en) 2009-03-13 2009-03-13 Novel thienopyrimidines
GB0911022A GB0911022D0 (en) 2009-06-26 2009-06-26 Novel purines
GB0911022.2 2009-06-26
PCT/EP2010/053318 WO2010103130A2 (en) 2009-03-13 2010-03-15 Novel bicyclic heterocycles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014228403A Division JP6021880B2 (ja) 2009-03-13 2014-11-10 免疫抑制剤としてのチアゾロピリミジン調節因子

Publications (3)

Publication Number Publication Date
JP2012520269A JP2012520269A (ja) 2012-09-06
JP2012520269A5 true JP2012520269A5 (https=) 2013-05-02
JP5647998B2 JP5647998B2 (ja) 2015-01-07

Family

ID=42181129

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011553476A Expired - Fee Related JP5647998B2 (ja) 2009-03-13 2010-03-15 免疫抑制剤としてのチアゾロピリミジン調節因子
JP2014228403A Expired - Fee Related JP6021880B2 (ja) 2009-03-13 2014-11-10 免疫抑制剤としてのチアゾロピリミジン調節因子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014228403A Expired - Fee Related JP6021880B2 (ja) 2009-03-13 2014-11-10 免疫抑制剤としてのチアゾロピリミジン調節因子

Country Status (6)

Country Link
US (2) US8901132B2 (https=)
EP (2) EP2405973B1 (https=)
JP (2) JP5647998B2 (https=)
CA (2) CA2754890C (https=)
ES (2) ES2665277T3 (https=)
WO (1) WO2010103130A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2035369T3 (da) 2006-07-05 2014-10-06 Fibrotech Therapeutics Pty Ltd Terapeutiske
ES2665277T3 (es) * 2009-03-13 2018-04-25 Katholieke Universiteit Leuven K.U. Leuven R&D Análogos de purina y su uso como agentes inmunosupresores
EP2491030B1 (en) 2009-10-22 2015-07-15 Fibrotech Therapeutics PTY LTD Fused ring analogues of anti-fibrotic agents
GB201012889D0 (en) 2010-08-02 2010-09-15 Univ Leuven Kath Antiviral activity of novel bicyclic heterocycles
GB201015411D0 (en) * 2010-09-15 2010-10-27 Univ Leuven Kath Anti-cancer activity of novel bicyclic heterocycles
GB201114212D0 (en) 2011-08-18 2011-10-05 Ucb Pharma Sa Therapeutic agents
GB201115665D0 (en) 2011-09-09 2011-10-26 Univ Leuven Kath Autoimmune and inflammatory disorder therapy
US20130102601A1 (en) 2011-10-21 2013-04-25 F. Hoffmann-La Roche Ltd Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease
GB201119401D0 (en) 2011-11-10 2011-12-21 Ucb Pharma Sa Therapeutic agents
GB201217704D0 (en) 2012-10-03 2012-11-14 Ucb Pharma Sa Therapeutic agents
SG11201504291SA (en) * 2012-12-20 2015-07-30 Ucb Biopharma Sprl Therapeutically active pyrazolo-pyrimidine derivatives
CN103044460B (zh) * 2013-01-30 2015-02-25 石家庄学院 3,5,7-三苯基-5H-噻唑并[3,2-a]嘧啶类衍生物及应用
MA38455B1 (fr) * 2013-04-05 2018-05-31 Polichem Sa Utilisation de pidotimodes pour traiter la maladie inflammatoire de l'intestin
BR112016006319A2 (pt) 2013-09-27 2017-08-01 Nimbus Iris Inc inibidores de irak e usos dos mesmos
TWI648281B (zh) 2013-10-17 2019-01-21 日商安斯泰來製藥股份有限公司 含硫二環式化合物
CN104892589A (zh) * 2014-03-07 2015-09-09 中国科学院上海药物研究所 一类杂环化合物、其制备方法和用途
GB201410817D0 (en) 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
US9822127B2 (en) * 2014-07-23 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University GAK modulators as antivirals
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
MX2017005462A (es) 2014-11-05 2017-07-28 Flexus Biosciences Inc Agentes inmunorreguladores.
GB201517263D0 (en) 2015-09-30 2015-11-11 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents
GB201521767D0 (en) 2015-12-10 2016-01-27 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R&D Therapeutic agents
CA3052036A1 (en) 2017-02-03 2018-08-09 Certa Therapeutics Pty Ltd. Anti-fibrotic compounds
SG11202012616RA (en) 2018-08-21 2021-02-25 Kyorin Pharmaceutical Co Ltd Bicyclic heteroaromatic ring derivative

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2512572A (en) 1950-06-20 Substituted pteridines and method
BE791242A (fr) * 1971-11-11 1973-05-10 Thomae Gmbh Dr K Nouvelles thiazolo(5,4-d)pyrimidines
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
ZA857647B (en) * 1984-10-12 1986-05-28 Warner Lambert Co Purine derivatives
NZ225447A (en) * 1987-07-20 1991-12-23 Merck & Co Inc Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions
US5057517A (en) * 1987-07-20 1991-10-15 Merck & Co., Inc. Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
GB9221220D0 (en) 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
JP2001097979A (ja) * 1999-07-28 2001-04-10 Takeda Chem Ind Ltd 縮合複素環化合物、その製造法および用途
US6331547B1 (en) 1999-08-18 2001-12-18 American Home Products Corporation Water soluble SDZ RAD esters
DE60101372T2 (de) 2000-02-11 2004-10-14 Astrazeneca Ab Pyrimidinverbindungen und ihre verwendung als modulatoren der chemokin-rezeptor-aktivität
US6440991B1 (en) 2000-10-02 2002-08-27 Wyeth Ethers of 7-desmethlrapamycin
JP2004028376A (ja) 2002-06-21 2004-01-29 Hino Motors Ltd Egrクーラ
WO2004035740A2 (en) * 2002-10-15 2004-04-29 Synta Pharmaceuticals Corp. Aromatic bicyclic heterocyles to modulate 1l - 12 production
JP4279784B2 (ja) * 2002-12-04 2009-06-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 1,3−ジヒドロ−イミダゾール縮合環化合物
ES2217956B1 (es) * 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
PL1641803T6 (pl) 2003-06-11 2011-04-29 Xention Ltd Pochodne tienopirymidyny jako inhibitory kanału potasowego
DE10348023A1 (de) * 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
US20080269238A1 (en) 2004-04-01 2008-10-30 Takeda Pharmaceutical Company Limited Thiazolopyrimidine Derivative
GB0407723D0 (en) * 2004-04-05 2004-05-12 Novartis Ag Organic compounds
US7576080B2 (en) 2004-12-23 2009-08-18 Memory Pharmaceuticals Corporation Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
FR2880626B1 (fr) * 2005-01-13 2008-04-18 Aventis Pharma Sa Derives de la purine, compositions les contenant et utilisation
CA2595882A1 (en) * 2005-01-26 2006-08-03 Pharmacia & Upjohn Company Llc Thieno [2,3-d] pyrimidine compounds as inhibitors of adp-mediated platelets aggregation
US20090149452A1 (en) 2005-07-01 2009-06-11 Nippon Chemiphar Co., Ltd. Xanthine oxidase inhibitor
GB0526246D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
WO2007084815A2 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica, N.V. Substituted thienopyrimidine kinase inhibitors
KR100846988B1 (ko) 2006-03-06 2008-07-16 제일약품주식회사 신규한 티에노피리미딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 함유하는 약학조성물
CN101511840A (zh) * 2006-04-26 2009-08-19 吉宁特有限公司 磷酸肌醇3-激酶抑制剂化合物及其使用方法
JP5026511B2 (ja) 2006-05-18 2012-09-12 エフ.ホフマン−ラ ロシュ アーゲー アデノシンa2bレセプターアンタゴニストとしてのチアゾロ−ピラミジン/ピリジン尿素誘導体
WO2008005303A2 (en) * 2006-06-30 2008-01-10 Janssen Pharmaceutica N.V. Thiazolopyrimidine modulators of trpv1
ZA200900670B (en) 2006-08-08 2010-04-28 Millennium Pharm Inc Heteroaryl compounds useful as inhititors of E1 activating enzymes
WO2008057402A2 (en) 2006-11-02 2008-05-15 Cytovia, Inc. N-aryl-isoxazolopyrimidin-4-amines and related compounds as activators of caspases and inducers of apoptosis and the use thereof
JP2010510211A (ja) 2006-11-16 2010-04-02 ファーマコペイア・リミテッド・ライアビリティ・カンパニー 免疫抑制用7−置換プリン誘導体
WO2008059368A2 (en) * 2006-11-17 2008-05-22 Pfizer Products Inc. Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
ES2571028T3 (es) * 2006-12-07 2016-05-23 Genentech Inc Compuestos inhibidores de fosfoinositida 3-cinasa y métodos de uso
JP2010526027A (ja) 2007-01-23 2010-07-29 パラウ・フアルマ・ソシエダツド・アノニマ プリン誘導体
CN101622001A (zh) 2007-01-26 2010-01-06 Irm责任有限公司 作为激酶抑制剂用于治疗疟原虫相关疾病的嘌呤化合物和组合物
WO2008135232A1 (en) 2007-05-02 2008-11-13 Riccardo Cortese Use and compositions of purine derivatives for the treatment of proliferative disorders
US7893060B2 (en) * 2007-06-12 2011-02-22 F. Hoffmann-La Roche Ag Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
CA2691444C (en) 2007-06-29 2016-06-14 Gilead Sciences, Inc. Purine derivatives and their use as modulators of toll-like receptor 7
WO2009013545A2 (en) * 2007-07-26 2009-01-29 Astrazeneca Ab Chemical compounds
WO2009027732A1 (en) * 2007-08-24 2009-03-05 Astrazeneca Ab 5-6-bicyclic heteroaromatic compounds with antibacterial activity
WO2009042607A1 (en) * 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
UA104010C2 (en) * 2008-12-18 2013-12-25 Эли Лилли Энд Компани Purine compounds
ES2665277T3 (es) * 2009-03-13 2018-04-25 Katholieke Universiteit Leuven K.U. Leuven R&D Análogos de purina y su uso como agentes inmunosupresores
AR080711A1 (es) * 2010-03-31 2012-05-02 Lilly Co Eli Compuesto de piperazin-purina composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento o prevencion del dolor

Similar Documents

Publication Publication Date Title
JP2012520269A5 (https=)
JP6021880B2 (ja) 免疫抑制剤としてのチアゾロピリミジン調節因子
US9730944B2 (en) Antiviral activity of novel bicyclic heterocycles
WO2012035423A1 (en) Anti-cancer activity of novel bicyclic heterocycles
RU2336275C2 (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция
SI3106463T1 (en) Compounds of substituted pyrazolo (1,5-) pyrimidine as inhibitors of TRK kinase
CA2473026A1 (en) 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
JP2012501312A5 (https=)
WO2000012497B1 (en) Quinazoline derivatives as medicaments
JP2012532131A5 (https=)
JP2016515098A5 (https=)
CN108366992A (zh) 蛋白水解靶向嵌合体化合物及其制备和应用方法
CA2385269A1 (en) Novel thiazolo(4,5-d)pyrimidine compounds
CA2407593A1 (en) Fused heteroaryl derivatives
RU2005101406A (ru) Производные пиримидинсульфонамида в качестве модуляторов рецепторов хемокинов
JP2003528880A5 (https=)
JP2018515526A5 (https=)
JP2017501983A5 (https=)
WO2004094431A3 (en) 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
RU2014109748A (ru) Морфолино-замещенные производные бициклических пиримидинмочевины или карбамата в качестве ингибиторов mtor
JP2005513020A5 (https=)
FI3909584T3 (fi) Pyrimidiiniyhdiste tai sen suola
JP2006512366A5 (https=)
PE20061193A1 (es) DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
RU2016109792A (ru) Новые соединения-антагонисты рецептора нейрокинина-1